These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37452432)

  • 21. PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor.
    Airiau K; Mahon FX; Josselin M; Jeanneteau M; Belloc F
    Cell Death Dis; 2013 Oct; 4(10):e827. PubMed ID: 24091670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N
    Gao Z; Li C; Sun H; Bian Y; Cui Z; Wang N; Wang Z; Yang Y; Liu Z; He Z; Li B; Li F; Li Z; Wang L; Zhang D; Yang L; Xu Z; Li X; Xu H
    Cell Death Differ; 2023 Feb; 30(2):544-559. PubMed ID: 36528756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph
    Willmann M; Sadovnik I; Eisenwort G; Entner M; Bernthaler T; Stefanzl G; Hadzijusufovic E; Berger D; Herrmann H; Hoermann G; Valent P; Rülicke T
    Exp Hematol; 2018 Jan; 57():50-59.e6. PubMed ID: 29031704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-X
    Kehr S; Haydn T; Bierbrauer A; Irmer B; Vogler M; Fulda S
    Cancer Lett; 2020 Jul; 482():19-32. PubMed ID: 32145345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.
    Giles FJ; Rosti G; Beris P; Clark RE; le Coutre P; Mahon FX; Steegmann JL; Valent P; Saglio G
    Expert Rev Hematol; 2010 Dec; 3(6):665-73. PubMed ID: 21091142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Casein kinase I inhibitor D4476 influences autophagy and apoptosis in chloroquine-induced adult retinal pigment epithelial-19 cells.
    Nguyen Hoang AT; Lee H; Lee SJ
    Exp Eye Res; 2022 May; 218():109004. PubMed ID: 35219693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma.
    Gao S; Chen T; Li L; Liu X; Liu Y; Zhao J; Lu Q; Zeng Z; Xu Q; Huang D; Tu K
    Front Cell Dev Biol; 2020; 8():587389. PubMed ID: 33195243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3p.
    Sukegawa M; Wang X; Nishioka C; Pan B; Xu K; Ohkawara H; Hamasaki Y; Mita M; Nakamura K; Okamoto M; Shimura H; Ohta M; Ikezoe T
    Leuk Res; 2017 Jul; 58():83-90. PubMed ID: 28501737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nilotinib: a new tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.
    Jarkowski A; Sweeney RP
    Pharmacotherapy; 2008 Nov; 28(11):1374-82. PubMed ID: 18956997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
    Bellodi C; Lidonnici MR; Hamilton A; Helgason GV; Soliera AR; Ronchetti M; Galavotti S; Young KW; Selmi T; Yacobi R; Van Etten RA; Donato N; Hunter A; Dinsdale D; Tirrò E; Vigneri P; Nicotera P; Dyer MJ; Holyoake T; Salomoni P; Calabretta B
    J Clin Invest; 2009 May; 119(5):1109-23. PubMed ID: 19363292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment.
    Weigel MT; Rath K; Alkatout I; Wenners AS; Schem C; Maass N; Jonat W; Mundhenke C
    Oncology; 2014; 87(4):232-45. PubMed ID: 25116401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
    Liu Y; Wang Z; Kwong SQ; Lui ELH; Friedman SL; Li FR; Lam RWC; Zhang GC; Zhang H; Ye T
    J Hepatol; 2011 Sep; 55(3):612-625. PubMed ID: 21251937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation.
    Li L; Wei J; Li S; Jacko AM; Weathington NM; Mallampalli RK; Zhao J; Zhao Y
    EBioMedicine; 2019 Jul; 45():553-562. PubMed ID: 31204278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradation.
    Park K; Lee JH
    Oncol Rep; 2009 Mar; 21(3):689-92. PubMed ID: 19212627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.
    Saydam G; Haznedaroglu IC; Kaynar L; Yavuz AS; Ali R; Guvenc B; Akay OM; Baslar Z; Ozbek U; Sonmez M; Aydin D; Pehlivan M; Undar B; Dagdas S; Ayyildiz O; Akin G; Dag IM; Ilhan O
    Hematology; 2018 Dec; 23(10):771-777. PubMed ID: 29996726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of nephrotoxicity induced by total terpenoids from Alismatis Rhizoma on HK-2 cells in vitro and its induction of apoptosis].
    Wang CF; Ma L; Feng L; Yin MR; Gu JF; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):490-497. PubMed ID: 28868869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspase-Independent Pathway is Related to Nilotinib Cytotoxicity in Cultured Cardiomyocytes.
    Yang Q; Zhang C; Wei H; Meng Z; Li G; Xu Y; Chen Y
    Cell Physiol Biochem; 2017; 42(6):2182-2193. PubMed ID: 28813698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma.
    Hugle M; Fulda S
    Cancer Lett; 2015 Apr; 360(1):1-9. PubMed ID: 25637161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.
    Cui X; Yu H; Yao J; Li J; Li Z; Jiang Z
    BMC Cancer; 2022 Dec; 22(1):1350. PubMed ID: 36564767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.
    Camgoz A; Gencer EB; Ural AU; Avcu F; Baran Y
    Leuk Lymphoma; 2011 Aug; 52(8):1574-84. PubMed ID: 21756066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.